FDA Inspection 969113 — New York Blood Center Enterprises
The FDA completed an inspection of New York Blood Center Enterprises on Apr 21, 2016 in New Hyde Park, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 21, 2016
- Fiscal Year
- 2016
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- New Hyde Park, NY (United States)